MARKET

PPH

PPH

VanEck Vectors Pharmaceutical ETF
NASDAQ

Real-time Quotes | Provided by Morningstar

75.84
-0.74
-0.97%
Closed 16:00 01/19 EST
OPEN
76.49
PREV CLOSE
76.58
HIGH
76.70
LOW
75.82
VOLUME
56.34K
TURNOVER
--
52 WEEK HIGH
78.16
52 WEEK LOW
65.24
TOTAL ASSET
368.47M
YTD YIELD
-1.48%
1D
5D
1M
3M
1Y
5Y
Dip Buyers Are Winning With $2.3 Billion of Leveraged Tech Bets
Bloomberg · 01/12 16:04
JPMorgan’s Bob Michele Says Hide in Cash With Treasury Yields Going Higher
Bloomberg · 01/11 19:59
Once Underdogs of Emerging Markets, Local Bonds Get Their Day
Bloomberg · 01/11 14:21
Bitcoin ETF Goes From Boom to Bust After a Record U.S. Debut
Bloomberg · 01/07 19:28
Alnylam’s CEO Says She’s Ready to Take Over From Biotech Legend
Bloomberg · 01/07 18:23
Microsoft and Alphabet Set for Worst Week Since Pandemic Start
Bloomberg · 01/07 16:09
Sleepless Bond Traders Face Worst Start to a Year in Decades
Bloomberg · 01/07 11:00
‘PPI’ ETF Aims to Hedge Inflation as Prices Keep Rising
Bloomberg · 01/03 18:33
More
No Data
Learn about the latest financial forecast of PPH. Analyze the recent business situations of VanEck Vectors Pharmaceutical ETF through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
Ratings
Date
Period
Agency
Ratings
08/31/2020
3 Year
Morningstar
08/31/2020
5 Year
Morningstar
  • Performance
  • Asset Allocation
  • Dividend History
Period
Return
Rank in Cat
1-Day
0.8574%
--
1-Week
-2.4151%
--
1-Month
-2.9895%
--
3-Month
-1.3098%
--
6-Month
4.8724%
--
YTD
-1.4781%
--
1-Year
12.4328%
--
3-Year
5.9871%
--
5-Year
0.5642%
--
Since Inception
8.8357%
--
No Data
No Data
  • All
No Data
Profile
Fund Name
VanEck Vectors Pharmaceutical ETF
Risk
Medium-low risk
Inception Date
2011-12-20
Benchmark
Dow Jones US Healthcare TR
Advisor Company
VanEck
Custodian
State Street Bank & Trust Co
Manager
Liao/Jin